Login Preferences
About News Publications Statistics Downloads API Guide License How to use Preferences
bn:02615702n
Noun Named Entity
SYL
No term available
EN
Brigatinib, sold under the brand name Alunbrig among others, is a small-molecule targeted cancer therapy being developed by Ariad Pharmaceuticals, Inc. Wikipedia
Relations
Sources
IS A
EN
compound
EN
medicine
PHYSICALLY INTERACTS WITH
EN
epidermal growth factor receptor
EN
insulin receptor

Please note that, in order to improve your browsing experience on this website, BabelNet® uses various types of cookies, including: browsing functionality, performance and statistical cookies.

By continuing to browse the site you are agreeing to our use of cookies. OK

License